Below you can find consensus from equity research analysts that currently cover Fluidra's stock (updated on a monthly basis).
FY 2024 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2.031 | 2.111 | 2.073 | 16 |
| Adjusted EBITDA | 450 | 474 | 466 | 16 |
| Adjusted EBITA | 369 | 392 | 377 | 10 |
| Cash Net Profit | 220 | 235 | 225 | 9 |
| Cash EPS | 1,12 | 1,22 | 1,17 | 11 |
| Net Working Capital | 343 | 497 | 387 | 14 |
| Net Debt | 1.022 | 1.219 | 1.096 | 14 |
FY 2025 (in €M):
| Metric | Min | Max | Average | Contr. |
|---|---|---|---|---|
| Sales | 2.114 | 2.230 | 2.186 | 16 |
| Adjusted EBITDA | 489 | 534 | 513 | 16 |
| Adjusted EBITA | 407 | 443 | 423 | 9 |
| Cash Net Profit | 241 | 271 | 260 | 8 |
| Cash EPS | 1.,26 | 1,41 | 1,36 | 9 |
| Net Working Capital | 331 | 527 | 401 | 14 |
| Net Debt | 861 | 1.129 | 982 | 1 |
* Data as of 21.10.2024
Notes:
- A total of 19 analysts cover Fluidra. The consensus presented above includes figures from those analysts who have published updated estimates over the last 6 months (16 analysts).
- The metrics compiled above are consistent with Fluidra's reporting metrics. Fluidra does not alter the figures in any way.